Robin Löving
Chief Scientific Officer Salipro Biotech
Robin Löving, Chief Scientific Officer (CSO) at Salipro Biotech. Robin has more than 20 years’ experience working with therapeutically relevant membrane protein targets. He did his PhD with a focus on membrane proteins and antigen design at the Karolinska Institute in Stockholm, Sweden. After being involved in other biotech startup companies, he joined Salipro Biotech as CSO eight years ago. Robin’s work has resulted in numerous granted patents and peer-reviewed publications.
Seminars
Wednesday 10th December 2025
Capturing Native GPCR Structures to Accelerate Drug Discovery
4:15 pm
- Incorporating wild-type GPCRs into nanomembrane particles to facilitate the discovery of small molecules, antibodies, and peptides
- Enabling the study of GPCR oligomerisation, comparing results from recombinant versus endogenously expressed receptors
- Discovering how combining structural biology with antibody discovery in a CXCR4- focused study led to the identification of promising therapeutic candidates
